The study drug is exploring a potential new treatment for conditions where the body's immune system mistakenly attacks healthy tissues, organs or cells.
We are evaluating the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of a potential new treatment for autoimmune diseases in healthy volunteers. Autoimmune diseases cause the immune system to attack the body, leading to inflammation and damage. Current treatments may not fully address the underlying biological processes contributing to these symptoms.
This initial phase is crucial before testing the study medication in patients with these conditions. By participating, you will contribute to research that could enhance future treatments and positively impact individuals and families affected by these diseases.
Call us on 1300 572 531 to discuss your eligibility today!